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ABSTRACT 
Primary human hepatocytes (PHHs) remain the gold standard for in vitro investigations of xenobiotic metabo-
lism and hepatotoxicity. However, scarcity of liver tissue and novel developments in liver surgery has limited 
the availability and quality of tissue samples. In particular, warm ischemia shifts the intracellular metabolism 
from aerobic to anaerobic conditions, which increases glycogenolysis, glucose depletion and energy deficiency. 
Therefore, the aim of the present study was to investigate whether supplementation with glucose and insulin dur-
ing PHH isolation could reconstitute intracellular glycogen storage and beneficially affect viability and function-
ality. Furthermore, the study elucidated whether the susceptibility of the tissue’s energy status correlates with 
body mass index (BMI). PHHs from 12 donors were isolated from human liver tissue obtained from partial liver 
resections using a two-step EDTA/collagenase perfusion technique. For a direct comparison of the influence of 
glucose/insulin supplementation, we modified the setup, enabling the parallel isolation of two pieces of one tis-
sue sample with varying perfusate. Independent of the BMI of the patient, the glycogen content in liver tissue 
was notably low in the majority of samples. Furthermore, supplementation with glucose and insulin had no bene-
ficial effect on the glycogen concentration of isolated PHHs. However, an indirect improvement of the availabil-
ity of energy was shown by increased viability, plating efficiency and partial cellular activity after supplementa-
tion. The plating efficiency showed a striking inverse correlation with increasing lipid content of PHHs. Howev-
er, 60 h of cultivation time revealed no significant impact on the maintenance of albumin and urea synthesis or 
xenobiotic metabolism after supplementation. In conclusion, surgical procedures and tissue handling may de-
crease hepatic energy resources and lead to cell stress and death. Consequently, PHHs with low energy resources 
die during the isolation process without supplementation of glucose/insulin or early cell culture, while their sur-
vival rates are improved with glucose/insulin supplementation. 
 
Keywords: Human liver, primary human hepatocytes, hepatocyte isolation, hepatic energy metabolism, cyto-
chrome P450 
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IMPACT STATEMENT 
Primary human hepatocytes (PHHs) are 
still considered the gold standard for in vitro 
investigations and are valuable resources in 
the field. However, their usage is limited by 
the availability of high-quality human liver 
tissue. Therefore, further adaptation and op-
timization of liver cell isolation procedures 
are crucial. In the current work, we showed 
that the viability and adherence of PHHs 
could be improved by supplementation with 
glucose and insulin during the isolation pro-
cedure. The data also revealed for the first 
time that different isolation procedures lead 
to a selection process on hepatocyte subpop-
ulations displayed by varying hepatic func-
tions. This information is crucial because it 
shows the impact of the isolation procedure 
on the functionality of PHH cultures. Conse-
quently, we recommend supplementation 
with glucose and insulin because it improves 
the majority of PHH batches and leads to a 
cell suspension that better reflects the PHH 
populations of the whole liver lobule. 
 
Abbreviations 
4-MU 4-methylumbelliferone 
BCA Bicinchoninic acid assay 
BSA Bovine serum albumin 
BMI body mass index 
CYP Cytochrome P450 enzymes 
DMSO Dimethyl sulfoxide 
FBS fetal bovine serum 
G6P glucose-6-phosphate 
GK glucokinase 
GLUT2 glucose transporter 2 
GST glutathione-S-transferase 
HLCH high lipid containing hepatocytes 
LLCH low lipid containing hepatocytes 
MCB monochlorobimane 
NEAA non-essential amino acids 
PBS Phosphate-buffered saline 
PHHs primary human hepatocytes 
ROS reactive oxygen species 
SRB sulforhodamine B 
w G+I with 11 mM D-Glucose and 
40 IU/l human insulin 
WME William’s Medium E 
w/o G+I without 11 mM D-Glucose and 
40 IU/l human insulin 
XTT 2.3-Bis-(2-Methoxy-4-Nitro-5-
Sulfophenyl)-2H-Tetrazolium-5-
Carboxanilide 
 
INTRODUCTION 
Primary human hepatocytes (PHHs) are 
an essential cellular tool in hepatology and 
toxicology. These cells are used in hepato-
cyte transplantation, which is under investi-
gation as an alternative therapeutic strategy 
to orthotopic liver transplantation in selected 
liver disorders. Additionally, these cells are 
applied in bioartificial liver devices in acute 
liver diseases, either as a bridge to transplan-
tation or to maintain liver functions until the 
liver tissue has regenerated. 
PHHs are also useful as an in vitro tool in 
medical, pharmacological and toxicological 
research. The cells are still considered the 
gold standard for the evaluation of in vitro 
metabolism and hepatotoxicity during the 
development of novel drugs and chemical 
compounds. Moreover, hepatocytes have 
been broadly used in physiological and path-
ophysiological model systems for investiga-
tions on hepatic functions in health and dis-
ease. A major drawback in the use of PHHs 
is their limited availability in high quality. 
The tissue originates from explanted dis-
eased livers (Kleine et al., 2014; Lloyd et al., 
2004; Richert et al., 2004), rejected livers not 
used for liver transplantation (Lloyd et al.; 
2004) and liver resection specimens (Kegel 
et al., 2016). However, surgical procedures 
with prolonged warm ischemia times due to 
the Pringle maneuver, laparoscopic liver re-
section (Horner et al., 2016) or preoperative 
portal vein embolization (Kluge et al., 2016) 
may impair PHH quality (Lloyd et al., 2004; 
Richert et al., 2004) or even limit the source 
of PHHs. The outcome of the cell isolation 
procedure itself depends on donor character-
istics (e.g., blood values, body mass index 
(BMI), and liver inflammation), tissue pro-
cessing and cell isolation conditions (Meng 
et al., 2016; Richert et al., 2004). In particu-
lar, the time delay between hepatectomy and 
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the beginning of liver perfusion has been 
discussed as the most critical factor influenc-
ing the success of PHH isolation (Bhogal et 
al., 2011). This time frame is characterized 
by warm and cold ischemia times in vivo and 
ex vivo, and a correlation of increasing is-
chemia times with decreasing PHH yield and 
viability has been shown (Lee et al., 2014). 
Moreover, PHH quality can be influ-
enced by dedifferentiation associated with 
the loss of physiological and morphological 
functions during cultivation. This process is 
already initiated in the isolation procedure 
due to the damage of cell contacts and con-
siderable ischemia reperfusion injury (Vin-
ken et al., 2012). 
Hepatocytes play a major role in system-
ic energy metabolism and supply the organ-
ism with metabolites during starvation peri-
ods (Rui, 2014). When hepatocytes are stim-
ulated with insulin, glucose can be converted 
to storage lipids and glycogen (Knobeloch et 
al., 2012). Blood glucose enters the hepato-
cytes via glucose transporter 2 (GLUT2) and 
is phosphorylated by glucokinase (GK) to 
generate glucose-6-phosphate (G6P) in the 
cells. This leads to a reduction of the intra-
cellular glucose concentration and a further 
increase in glucose uptake. In the fed state, 
G6P acts as a precursor for glycogen synthe-
sis. Alternatively, G6P might also be metab-
olized during glycolysis and further com-
pletely oxidized to maintain the intracellular 
ATP level (Rui, 2014). 
Warm ischemia during surgery and the 
cell isolation procedure shift the intracellular 
metabolism from aerobic to anaerobic condi-
tions, thereby increasing glycogenolysis and 
cellular membrane damage (Isaksson et al., 
2011). Therefore, prolonged ischemia reduc-
es intracellular glucose levels and depletes 
glycogen storage, resulting in a fasted state 
of the liver. Low levels of glycogen will af-
fect the cellular defense against reperfusion 
injury (Younes and Strubelt, 1988) and cell 
regeneration during the attachment phase in 
cell culture. In hepatocyte culture, an insulin-
supplemented medium has been shown to 
improve PHH attachment and morphology 
(Fraczek et al., 2013). Therefore, the aim of 
the present study was to investigate whether 
the supplementation of the perfusate with 
glucose and insulin during PHH isolation 
could reconstitute intracellular glycogen 
storage and has a beneficial effect on the vi-
ability and functionality of PHHs. Further-
more, it was elucidated whether the suscep-
tibility of the energy status and the glycogen 
level of the tissue and cells correlate with the 
BMI. 
 
MATERIAL AND METHODS 
Culture media and chemicals 
The hepatocyte attachment and culture 
medium was based on William’s Medium E 
with GlutaMAX™ (WME, Gibco, Paisley, 
UK), supplemented with 10 % fetal bovine 
serum (FBS, Merck Biochrom, Berlin, Ger-
many), 15 mM HEPES, 0.1 mM non-
essential amino acids (MEM NEAA 100x), 
1 mM sodium pyruvate, 100 U/100 µM pen-
icillin/streptomycin (all provided by Gibco, 
Paisley, UK), 80 IU/l human insulin (Lilly 
Deutschland GmbH, Bad Homburg, Germa-
ny) and 1 µg/ml dexamethasone (Forte-
cortin®, Merck, Darmstadt, Germany). Phos-
phate-buffered saline solution supplemented 
with calcium and magnesium (PBS) was 
purchased from Gibco and Trypan Blue was 
provided by Biochrom (Berlin, Germany). 
All other chemicals were purchased from 
Sigma-Aldrich (Munich, Germany), if not 
stated otherwise. Rat tail collagen was pre-
pared in our laboratory according to the pro-
tocol established by Rajan et al. (2006). 
 
Tissue samples 
Liver tissue samples were obtained from 
macroscopically healthy tissue that remained 
from resected human liver of patients with 
primary or secondary liver tumors or benign 
local liver diseases (Table 1 and Supplemen-
tary Table 1). Informed consent of the pa-
tients for the use of tissue for research pur-
poses was obtained according to the ethical 
guidelines of Leipzig University Hospital 
and Charité University Medicine Berlin. A 
part of the tissue samples was snap-frozen 
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and stored at -80 °C for later characteriza-
tion. 
 
Isolation of hepatocytes 
PHH were isolated from liver tissue 
samples by a two-step EDTA/collagenase 
perfusion technique as described elsewhere 
(Kegel et al., 2016) with the following modi-
fication: the liver tissue sample was cut into 
two approximately equal parts. Each part 
was cannulated and perfused in parallel us-
ing a pericyclic pump Cyclo 2 (Carl Roth, 
Karlsruhe, Germany) with two pump heads 
connected to Perfusion Solution I without 
(w/o G+I) or with (w G+I) 11 mM D-
Glucose and 40 IU/l human insulin (Fig-
ure 1). The glucose and insulin concentration 
based on identical concentrations used in the 
PHH culture medium for later cell culture. 
The second perfusion step was performed us-
ing the same collagenase P containing Perfu-
sion Solution II for digestion of both liver 
tissue pieces. In the ongoing isolation proce-
dure, the liver tissue pieces were treated in-
dividually. The resulting PHH fractions were 
washed with PBS and resuspended in PHH 
culture medium. Afterwards, the cell number 
and viability was determined in a Neubauer 
counting chamber by Trypan blue. The cells 
were snap-frozen and stored at -80 °C for 
later characterization or seeded on cell cul-
ture plastics (Supplementary Figure 1). 
 
Tissue and cell lysis 
PHHs were treated with lysis buffer con-
sisting of PBS supplemented with 
0.1 % SDS, 0.5 % Triton X-100 and 
50 mM Trizma HCL and frozen at -20 °C. 
Cultured cells were lysed by freeze-thaw cy-
cles and protein samples were collected by 
scratching using a cell scraper. In contrast, 
liver tissue samples were thawed and dis-
rupted using a TissueLyser 2 (Qiagen, Hil-
den, Germany) at a speed of 30 Hz for 1 min. 
Samples were resuspended in ddH2O and 
sonicated for at least 10 min (Son-
orex RK 100, Bandelin, Berlin, Germany). 
Aliquots were taken for protein and glycogen 
quantification. 
 
 
Table 1: Donor data for tissue samples used for PHH isolation. Summary of donors including sex, 
age, medical history and body mass index (BMI). Samples were grouped according to BMI as low (L) 
with BMI < 25 or high (H) with BMI ≥ 25. 
Donor Sex Age Disease Secondary diagnosis BMI 
D1-L male 28 echinococcosis slight portal fibrosis, nicotine con-
sumption 
19.4 
D2-L female 77 colorectal liver  
metastasis 
diabetes mellitus, steatosis 
(< 5 %), slight portal fibrosis, ne-
crosis 
23.3 
D3-L male 44 echinococcosis none 24.7 
D4-L female 46 bile duct cyst diabetes mellitus 18.4 
D5-L female 79 intrahepatic cholan-
giocarcinoma 
none 20.0 
D6-L female 74 intrahepatic cholan-
giocarcinoma 
none 24.1 
D1-H female 73 colorectal liver  
metastasis 
steatosis (25 %), slight portal  
fibrosis, necrosis  
26.3 
D2-H female 44 adenoma arterial hypertension 30.5 
D3-H male 55 hemangioma non-alcoholic fatty liver disease 
(15-45 %), slight portal fibrosis 
30.6 
D4-H male 60 Klatskin tumor nicotine and alcohol consumption 27.7 
D5-H male 80 hepatocellular  
carcinoma 
diabetes mellitus type 2, steatosis 
(10 %), slight fibrosis 
29.4 
D6-H male 77 hepatocellular  
carcinoma 
diabetes mellitus type 2, steato-
sis, nicotine consumption 
31.0 
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Figure 1: Schematic illustration of the experimental procedure. Every human liver tissue sample 
was dissected into two almost equal parts. Each liver piece was cannulated to first perfuse it in parallel 
with an EGTA-containing Perfusion solution I either without (w/o G+I) or with (w G+I) 11 mM D-
Glucose and 40 IU/l human insulin. The second perfusion step was performed using the same colla-
genase P-containing Perfusion Solution II for digestion. Using one centrifugation step per liver tissue 
sample, two separate fractions of primary human hepatocytes were obtained. 
 
 
 
Biochemical glycogen assay 
Glycogen content was determined quan-
titatively by an enzymatic cleavage in glu-
cose following glucose determination closely 
related to the method of Lust et al. (1975). 
Glycogen was measured in samples from su-
pernatants from lysed cells or tissue. Glyco-
gen content was normalized on protein con-
tent measured from the same sample using 
Bicinchoninic acid assay (BCA). A serial 
calibration curve using glycogen from oyster 
with a concentration range of 125 µg/ml to 
6 mg/ml in ddH2O was prepared. Calibration 
standards, samples and blank were treated 
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with 7 % perchloric acid in ddH2O (pH 1.2) 
and suspended carefully to terminate remain-
ing enzyme functions. The reaction mixtures 
were alkalized by adding 0.5 M sodium hy-
droxide (Carl Roth, Karlsruhe, Germany) 
and heated in covered tubes to 100 °C for 
10 min (Thermomixer pro, CellMedia, El-
steraue, Germany). The reaction tubes were 
centrifuged at 500 x g for 30 sec at 4 °C 
(Centrifuge 5424 R, Eppendorf) and 2 M ac-
etate buffer (pH 4.5) containing 4 mg/ml 
amyloglucosidase was added to each cooled 
solution. All reaction mixtures were incubat-
ed at 55 °C for 2 h. Glucose determination 
was performed with Fluitest Glucose-Assay 
(Analyticon, Lichtenfels, Germany) accord-
ing to the manufacturer’s instructions. 
 
Determination of protein content 
Protein content of frozen PHH cell pel-
lets was determined using a BCA assay. A 
serial calibration curve using bovine serum 
albumin (BSA) in a concentration range of 
31.25 µg/ml to 2 mg/ml was prepared. The 
samples were diluted to a concentration in 
the range of the calibration standard. Tripli-
cates of sample, calibration standard or 
ddH2O (blank) were transferred to a 96-well 
plate (BD Falcon, Heidelberg, Germany or 
Greiner Bio-One, Frickenhausen, Germany). 
All wells were incubated with the reaction 
mixture consisting of BCA reagent A and 
4 % copper sulfate solution in a ratio of 1:50, 
respectively. After incubating for 30 min in 
the dark, the absorbance was measured at a 
wavelength of 563 nm using a microplate 
reader (FLUOstar OPTIMA, BMG Labtech, 
Ortenberg, Germany or Synergy H1, BioTek, 
Bad Friedrichshall, Germany). 
 
Culture of hepatocytes 
PHHs were cultured for up to 48 h in a 
classic 2D culture. Therefore, PHHs were 
seeded at a density of 110000/cm2 on rat tail 
collagen-coated cell culture plates (Greiner 
Bio-One, Frickenhausen, Germany) in PHH 
culture medium. Experiments were per-
formed after an initial adherence period of 
14-16 h (T0) and additional 24 h (T1) and 
48 h (T2) (Supplementary Figure 1). 
 
Oil Red O staining 
The diazo dye visualizes intracellular tri-
acylglycerides - in PHH 16 h after seeding 
(T0), cell culture medium was removed and 
cells were washed twice with PBS. Cells 
were fixed with 4 % Roti®-Histofix (Carl 
Roth, Karlsruhe, Germany) for 30 min. Cells 
were gently washed two times with ddH2O 
and once for 5 min with 60 % 2-propanol 
(≥ 99.5 %, Carl Roth, Karlsruhe, Germany) 
in ddH2O. After allowing the cells to dry, 
they were incubated for 20 min at room tem-
perature with filtered Oil Red O working so-
lution. For this, an Oil Red O stock solution 
consisting of 3.5 mg/ml Oil Red O in 
2-propanol (≥ 99.5 %) was mixed with 
ddH2O in a ratio of 3:2. After the incubation 
period, cells were washed three times with 
ddH2O to remove non-fixed dye. Finally, 
cells were dried and the Oil Red O stain was 
extracted with 2-propanol for 5 min with 
gentle rocking. Absorbance was measured at 
550 nm using a microplate reader. For nor-
malization, protein content was evaluated us-
ing sulforhodamine B (SRB) protein stain-
ing. 
 
Sulforhodamine B (SRB) protein staining 
The protein dye SRB binds basic amino 
acids residues, so the results are linear with 
cellular protein and cell number. After the 
previous Oil Red O assay, cells were washed 
twice with ddH2O and covered with SRB so-
lution for 30 min at room temperature with 
gentle rocking and protected from light. Un-
bound SRB was removed by washing four 
times with 1 % acetic acid (Carl Roth, Karls-
ruhe, Germany) in ddH2O. For quantifica-
tion, SRB was extracted from cells under 
mild basic conditions with 10 mM 
un-buffered TRIS solution (pH 10 - 10.5) in-
cubating 10 min at room temperature by gen-
tle rocking. Samples were diluted in a ratio 
of 1:10 to 1:20 and 100 µl of these solutions 
were transferred in triplicates to a 96-well 
plate. TRIS solution was used as an assay 
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control. Absorbance was measured at a 
wavelength of 565 nm due to SRB concen-
tration and at 690 nm as reference wave-
length using a microplate reader. 
 
XTT viability assay 
The Cell Proliferation Kit II (Roche, Ba-
sel, Switzerland) is a colorimetric cell viabil-
ity assay that detects cellular metabolic ac-
tivity. During the assay, the yellow tetrazoli-
um salt XTT (2.3-Bis-(2-Methoxy-4-Nitro-5-
Sulfophenyl)-2H-Tetrazolium-5-Carboxani-
lide) is reduced to a highly colored formazan 
dye in the presence of an electron-coupling 
reagent by dehydrogenase enzymes in viable 
cells. Thus, the amount of the formazan pro-
duced is proportional to viable cells in the 
sample. For this, 16 h after seeding (T0), cell 
culture medium was removed, cells were 
washed twice with PBS and starved for 4 h 
in PHH culture medium without FCS. After 
that, PHH starvation medium and XTT label-
ing mixture were added to each well accord-
ing to manufacturer’s instructions and incu-
bated for 6 h at 37 °C. Finally, 100 µl of 
these solutions were transferred in triplicates 
to a 96-well plate and the absorbance of the 
formazan dye was quantified at 450 nm us-
ing a microplate reader. For normalization, 
protein content was evaluated using SRB 
protein staining. 
 
Determination of urea 
For urea determination in the supernatant 
of cultured PHHs, an assay according to 
Zawada et al. (2009) was used. In brief: Both 
O-Phthalaldehyde and primaquine working 
solutions, containing 30 % Brij™-35 (Ther-
mo Scientific, Schwerte, Germany) were 
prepared and diluted with ddH2O. A calibra-
tion curve of urea was prepared in a concen-
tration range of 0.0035 mM to 4.16 mM by 
serial dilution. PHH culture medium was ful-
ly processed as the samples and used as an 
additional control. The assay was performed 
by placing 50 μl of sample, calibration 
standard, medium or ddH2O (blank) per well 
in triplicates in a 96-well cell culture plate 
(BD Falcon, Heidelberg, Germany). 100 μl 
of O-Phthalaldehyde reagent was added and 
the plate was shaken gently. Afterwards, 
100 μl of primaquine reagent were trans-
ferred into each well and incubated for 1 h at 
37 °C in the dark. The absorbance was 
measured at a wavelength of 430 nm using a 
microplate reader. Experiments were per-
formed after an initial adherence period of 
14-16 h (T0) and additional 24 h (T1) and 
48 h (T2). 
 
Determination of albumin 
Albumin, secreted to cell culture super-
natants, was measured with an ELISA 
(Bethyl Laboratories, Montgomery, USA) 
according to the manufacturer’s instructions. 
PHH culture medium was used as an assay 
control. Experiments were performed after 
an initial adherence period of 14-16 h (T0) 
and additional after 24 h (T1) and 48 h (T2). 
 
Determination of phase I and II enzyme  
activities 
The measurement of enzyme activities of 
phase I and phase II enzymes were per-
formed according to Collier et al. (2000) and 
Donato et al. (2004). Briefly, stock solutions 
of substrates and fluorescent metabolites 
were prepared in dimethyl sulfoxide 
(DMSO) and stored at -20 °C. PHHs were 
cultured as described above and medium was 
changed to starvation medium (without FBS 
and penicillin/streptomycin), 4 h prior the 
assay performance. Cells were treated with 
non-fluorescent substrates for phase I, which 
were converted to fluorescent metabolites by 
Cytochrome P450 enzymes (CYP), and fluo-
rescent substrates for phase II, which under-
go glucuronidation or sulfation (substrates 
are listed in Supplementary Table 2). Each 
incubation was performed in duplicates for 
90 min. The medium supernatant was trans-
ferred to a new 96-well plate afterwards. For 
an absolute quantification, calibration curves 
were prepared with the metabolites of 
phase I/substrates of phase II and measured 
in the same plate as the samples. Wells with 
fixed hepatocytes were used as negative con-
trols. 
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For the exclusive evaluation of phase I 
enzyme activity, the formed phase II me-
tabolites were cleaved by an incubation with 
100 U/ml β-glucuronidase and 100 U/ml sul-
fatase for 2 h. The increasing emissions of 
the fluorescent metabolites were determined 
at specific wavelengths using a microplate 
reader. 
In contrast to CYP enzyme activities, the 
phase II enzyme activities were determined 
with fluorescent substrates which were con-
verted to non-fluorescent metabolites. Addi-
tionally to the phase I products, 4-methylum-
belliferone (4-MU) for estimating glucu-
ronosyl-O-transferase activity and mono-
chlorobimane (MCB) for glutathione-S-
transferase (GST) activity were used. GST 
activity was relatively estimated since MCB 
shows no fluorescence and the fluorescent 
MCB conjugate was commercially not avail-
able. 
Experiments were performed after an ini-
tial adherence period of 14-16 h (T0) and ad-
ditional after 24 h (T1) and 48 h (T2). 
 
Statistical analysis 
Data were analyzed by two-way ANO-
VA and unpaired t-test with Welch’s correc-
tion using Graph Pad Prism 6 software. Re-
sults are given as mean ± SD. Differences 
were considered as significant at p < 0.05. 
Experiments were performed in PHHs or tis-
sue from different donors (N) and data were 
measured in technical replicates (n) as stated 
in figure legends. 
 
RESULTS 
Human liver tissue samples obtained from 
liver resections revealed low glycogen  
storage 
We hypothesized that the surgical proce-
dure and postsurgery ischemia time during 
the isolation process lead to the emptying of 
glycogen storages. Therefore, we analyzed 
liver tissue samples after hemihepatectomy 
of patients with low and high BMI (Supple-
mentary Table 1) for their glycogen content 
(Figure 2). Considering that full glycogen 
storage corresponds to approximately 8 % of 
the liver weight (Cole and Kramer, 2016), 
the majority of analyzed human liver tissue 
samples revealed decreased levels of glyco-
gen. Donors with a high BMI showed vary-
ing glycogen levels but, on average, higher 
glycogen values compared to samples from 
patients with low BMI. The glycogen storag-
es of patients with low BMI are only filled 
up to approximately 10 % of the maximum 
storage capacity. 
 
Supplementation of glucose and insulin 
during hepatocyte isolation improves the  
viability of hepatocytes 
We tested whether supplementation with 
glucose and insulin during the isolation pro-
cess is capable of influencing the isolation 
outcome. Therefore, we perfused the liver 
tissue samples with perfusion solution I con-
taining glucose and insulin for at least 
20 min as part of the isolation process in 
comparison to the established buffer without 
glucose and insulin (Figure 1). This supple-
mentation was only performed in perfusion 
step I; hence, the cells have time for the up-
take of glucose and insulin, and an impact of 
metabolism can be observed. 
Taken together, 12 donors with different 
BMIs were investigated in this study. All 
(N = 12) were analyzed for the isolation out-
come. Because the yield of isolated PHHs 
limited their use for characterization, the 
study was split into two substudies. Substudy 
1 (N = 6 D1-3-L & D1-3-H) investigates the 
effect of supplementation with glucose and 
insulin on PHH quality, while substudy 2 
(N = 6 D4-6-L & D4-6-H) investigates the 
effect of the modified protocol on the regen-
eration of hepatic functions of PHHs in cul-
ture. 
The characterization of freshly isolated 
PHHs (N = 12) revealed predominantly 
higher viabilities of PHHs after supplemen-
tation with glucose and insulin (Figure 3). In 
detail, PHHs of 7 isolations showed an in-
crease in viability, PHHs of 3 isolations ex-
hibited no effect and PHHs from 2 isolations 
had a decrease in viability when isolated 
with the modified protocol. In 4 cases, sup-
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plementation with glucose and insulin helped 
low-viability cells to exceed 70 %, which is 
a generally accepted quality criterion for 
many PHH applications (Godoy et al., 2013). 
Although the modified protocol revealed a 
clear trend to improve PHH viability, the sta-
tistical analysis did not show a significant re-
sult due to the varying values within a small 
range (Supplementary Figure 2). In contrast, 
an influence on the yield of isolated PHHs 
was not observable (Supplementary Fig-
ure 3). 
 
Cell quality of PHHs is influenced by their 
lipid content 
Within the scope of substudy 1, PHHs of 
six donors, half with low (D1-3-L) and half 
with high BMI (D1-3-H) were seeded and 
investigated in detail. The lipid content of 
the adherent PHHs was characterized using 
Oil Red O staining normalized to protein 
content measured by the SRB assay. Quanti-
fication of the relative lipid content of isolat-
ed PHHs revealed that a low BMI correlated 
with low lipid content. In contrast, only two 
out of three donors with high BMI showed 
increased lipid content (Figure 4). The PHHs 
from donor D1-H showed notably low lipid 
levels despite a BMI of 26.3, and although 
the resected liver tissue was clearly classified 
with hepatic steatosis higher than 25 % by 
the pathological unit from University Medi-
cine Leipzig (Supplementary Table 1). 
Therefore, the PHHs from donor D1-3-L, as 
well as D1-H, were regarded as low-BMI 
samples and classified as low lipid-
containing hepatocytes (LLCH). PHHs from 
D2-3-H were grouped as high lipid-
containing hepatocytes (HLCH). In LLCH, 
supplementation with glucose and insulin 
showed no or only a small change in the li-
pid content when isolated with the modified 
protocol. In contrast, the HLCH of the two 
donors showed a drop in the lipid content 
when supplemented with glucose and insulin 
during the cell isolation procedure. 
 
 
 
 
Figure 2: Glycogen content in human liver tissue. Amount of glycogen was measured in fresh tis-
sue before the isolation procedure for single donors (A) and grouped for donors with low and high 
body mass index (B). The red dashed line indicates the average glycogen amount in the liver of ap-
proximately 8 % (A). 
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Figure 3: Effect of perfusion without and with glucose/insulin supplementation on viability of 
isolated primary human hepatocytes. Cell viability was determined via trypan blue exclusion tech-
nique. The red dashed line indicates 70 % viability as a quality criterion of hepatocytes (Godoy et al., 
2013). For statistical analysis see Supplementary Figure 2. 
 
 
Figure 4: Impact of donors BMI on lipid content of hepatocytes after isolation procedure with-
out and with glucose/insulin supplementation of perfusion solution I. Lipid contents were meas-
ured with Oil Red O staining. Data are normalized on protein content via sulforhodamine B protein 
staining. Data are presented as mean ± SD, plotted as technical replicates (n = 3) (A). Data were 
summarized by their lipid content and are presented as mean ± SD, plotted as low lipid containing 
hepatocytes-group (LLCH, N = 4, n = 3) and high lipid containing hepatocytes-group (HLCH, N = 2, 
n = 3) (B). Single groups were analyzed by unpaired T-Test with Welch’s correction (** p = 0.0015). 
 
 
 
Supplementation of glucose and insulin 
during hepatocyte isolation improves the 
adherence of hepatocytes 
Characterization of seeded PHHs re-
vealed a positive effect on plating efficiency 
for the majority of PHHs isolated with a 
supplementation with glucose and insulin 
(Figure 5). There was a direct correlation be-
tween the adherence ability and the viability 
of hepatocytes. Again, PHHs isolated with 
supplementation of glucose/insulin from do-
nors with high BMI showed a more pro-
nounced improvement of the plating effi-
ciency. However, only donor D1-L (LLCH-
1) revealed a decrease in viability when sup-
plemented with glucose and insulin and 
showed markedly decreased adherence. 
 
Hepatocytes with high lipid content profit 
from glucose/insulin supplementation show-
ing a stabilization of energy metabolism 
The quantification of glycogen in isolat-
ed LLCH showed, in the majority of cases, 
no effect of glucose and insulin supplemen-
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tation on the glycogen content (Supplemen-
tary Figure 4). Only in HLCH from donor 
D2-H, who already had a moderate glycogen 
level, was the supplementation procedure 
able to increase the glycogen content. Addi-
tionally, measurement of the cell activity us-
ing the XTT assay revealed that LLCH 
showed mostly lower cell activity when iso-
lated with glucose and insulin supplementa-
tion compared to no supplementation. In 
contrast, HLCH showed increased cell ac-
tivity when isolated with the modified proto-
col (Figure 6). 
Taken together, supplementation with 
glucose and insulin during the cell isolation 
procedure showed no general improvement 
of glycogen storage. An increase in the gly-
cogen content was only observed when the 
glycogen level was already high. However, 
in the majority of PHHs, an increase in via-
bility was measured after supplementation 
independently of the BMI. This finding sug-
gests that the majority of PHHs took up glu-
cose, leading to a reduction in isolation stress 
and an improvement in viability. The benefi-
cial effect of glucose and insulin supplemen-
tation persists after seeding, leading to an in-
creased adherence of PHHs. However, PHHs 
with high lipid content (HLCH) showed a 
general loss in plating efficiency, suggesting 
a connection between lipid content and ad-
herence capacity. 
 
 
Figure 5: Effect of perfusion without and with glucose/insulin supplementation on adherence 
of isolated primary human hepatocytes (PHH). Cell adherence was measured with sulforhoda-
mine B protein staining. Data are presented as mean ± SD, plotted as technical replicates (n = 9) (A). 
Data are presented as mean ± SD, plotted as low lipid containing hepatocytes-group (N = 4, n = 9) 
and high lipid containing hepatocytes-group-group (N = 2, n = 9) (B). Single groups were analyzed by 
unpaired T-Test with Welch’s correction (*p = 0.0369, **** p < 0.0001). 
 
 
Figure 6: Effect of perfusion without and with glucose/insulin supplementation on primary hu-
man hepatocyte (PHH) activity in culture. The XTT assay was performed after initial adherence (T0) 
reflecting the cell activity differences directly after PHH isolation. Data are presented as mean ± SD, 
plotted as technical replicates (n = 9) and normalized on cell adherence (sulforhodamine B protein 
staining) (A). Data were summarized by their lipid content and are presented as mean ± SD, plotted 
as low lipid containing hepatocytes-group (N = 4, n = 9) and high lipid containing hepatocytes-group-
group (N = 2, n = 9) (B). 
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Energetic stabilization of PHHs has no  
impact on hepatocyte function in vitro 
Within the scope of substudy 2, we in-
vestigated whether the improved viability 
and adherence after glucose/insulin supple-
mentation also influenced the recovery of 
hepatocyte function in cell culture. There-
fore, PHHs of six other donors with low 
(D4-6-L) and high BMI (D4-6-H) were cul-
tured for 24 and 48 h, and the synthesis of 
albumin as a marker of protein synthesis and 
urea as a marker of metabolic capacity were 
measured. The initial albumin synthesis 
ranged between 200 and 400 ng/mg protein/h 
(Figure 7). The supplementation with glu-
cose and insulin had no effect in the majority 
of PHH batches. However, two PHH batches 
from donors with high BMI showed different 
values. The initial (T0) albumin synthesis 
rate changed after 24 and 48 h and showed a
 
 
Figure 7: Synthesis rate of albumin of plated primary human hepatocytes (PHHs). Albumin se-
creted by PHHs was determined by ELISA after initial adherence (T0) and additional 24 h (T1) and 
48 h (T2). Data are presented as mean ± SD, plotted as technical replicates (n = 3). 
 
EXCLI Journal 2019;18:1071-1091 – ISSN 1611-2156 
Received: September 02, 2019, accepted: October 29, 2019, published: November 18, 2019 
 
 
1083 
similar course, independent of whether 
PHHs were isolated without or with glucose 
and insulin supplementation. Therefore, the 
changes in synthesis rates were donor-
dependent and independent of BMI or sup-
plementation with glucose and insulin. 
Similarly, the initial urea synthesis re-
vealed donor-dependent capacities between 2 
and 12 µg/mg protein/h (Figure 8). The glu-
cose and insulin-supplemented PHHs 
showed similar or higher initial (T0) values 
of urea synthesis. Only in one donor (D5-H) 
the initial (T0) metabolic activities decreased 
to a lower value after glucose/insulin sup-
plementation. PHHs from donors with low 
BMI were able to keep their initial urea syn-
thesis stable for 48 h, while in PHHs from 
donors with high BMI, the urea synthesis 
further decreased in a time-dependent man-
ner. 
 
Figure 8: Synthesis rate of urea of plated primary human hepatocytes (PHHs). Urea secreted by 
PHH was determined after initial adherence (T0) and additional 24 h (T1) and 48 h (T2). Data are pre-
sented as mean ± SD, plotted as technical replicates (n = 3). 
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Enzymes of xenobiotic metabolism are 
markers of hepatic differentiation. Therefore, 
the activities of CYP450 enzymes as markers 
for phase I reactions, as well as selected con-
jugation reactions, as markers for phase II 
reactions were measured after an adherence 
phase (T0) and an additional 24 (T1) and 48 h 
(T2) using fluorescent probes (Figure 9, Sup-
plementary Tables 3 and 4). Two out of six 
donors (D4-L, D6-H) showed high CYP450 
enzyme activities independently of BMI. 
Glucose and insulin-supplemented PHHs 
showed lower initial activities compared to 
conventionally isolated PHHs. In the majori-
ty of cases, CYP450 activities decreased 
time-dependently and independently of BMI 
or isolation strategy. In contrast, the initial 
phase II activities showed more equally dis-
tributed high values with smaller donor-
dependent variations. One exception was the 
enzyme GSH transferase (substrate: MCB, 
Supplementary Table 4), which showed high 
activities in PHHs from one donor only. For 
the most part, the phase II activities were 
maintained or increased during the culture 
time. The supplementation with glucose and 
insulin showed no influence on the mainte-
nance of the phase II activities. 
Taken together, the investigation of he-
patic function showed high donor variability 
in protein synthesis, metabolic activity and 
xenobiotic metabolism. While supplementa-
tion with glucose and insulin initially leads 
to higher urea synthesis capacities and lower 
CYP activities, no differences in the initial 
albumin synthesis rate and phase II reactions 
were observed. Cell cultivation for 48 h re-
vealed that supplementation with glucose 
and insulin showed no late improvement of 
hepatic functions or maintenance of hepatic 
differentiation. 
 
DISCUSSION 
Despite the limited availability of prima-
ry human hepatocytes, they are still the gold 
standard for in vitro investigations of xeno-
biotic metabolism and hepatotoxicity. The 
improvements and novel developments in 
the field of liver surgery additionally affect 
the scarcity of tissue samples suitable for 
liver cell isolation (Horner et al., 2016; Ke-
gel et al., 2016; Kluge et al., 2016; Lloyd et 
al., 2004). Therefore, further adaptation and 
optimization of liver cell isolation proce-
dures are crucial. In the current work, we 
showed that viability and adherence could be 
improved by supplementing perfusion solu-
tion I with glucose and insulin. 
 
Influence of supplementation on initial 
hepatocyte quality 
The quality of isolated liver cells de-
pends on patient-related factors (Lee et al., 
2014) and intraoperative (Richert et al., 
2004) and postsurgery (Isaksson et al., 2011) 
ischemia times. Intraoperative investigations 
of ischemia-reperfusion injury during portal 
clamping revealed anaerobic metabolism, in-
creased glycogenolysis and cellular mem-
brane damage (Isaksson et al., 2011). There-
fore, we investigated the availability of ener-
gy equivalents in liver tissue from resected 
livers. As the availability of energy equiva-
lents depends on glycogen but also on lipid 
storage, we hypothesized a correlation with 
the systemic energetic state of the patient 
expressed by the BMI. 
The characterization of human liver tis-
sue samples of patients with low and high 
BMI revealed decreased levels of glycogen 
in almost all investigated samples, consider-
ing that full glycogen storage corresponds to 
8 % of liver weight (Cole and Kramer, 
2016). Donors with a high BMI showed var-
ying glycogen levels but, in the majority of 
cases, higher glycogen values compared to 
samples from patients with low BMI. The 
low BMI samples had approximately 10 % 
of the full glycogen capacity. 
As hepatocytes require glucose and gly-
cogen to survive warm and cold ischemia, as 
well as cellular stress during the isolation 
process, we hypothesized that supplementa-
tion with glucose and insulin during the iso-
lation process could help to improve cell 
quality. The supplementation of the perfusate 
with glucose was performed before and is 
part of some published protocols (Lee et al., 
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2013). However, the additional use of insulin 
to stimulate glucose uptake has not been 
previously described. To directly compare 
the influence of glucose/insulin supplemen-
tation, we modified the isolation setup, al-
lowing the parallel isolation of two pieces of 
one tissue sample with varying perfusion so-
lutions. 
 
 
 
Figure 9: Determination of phase I and phase II enzyme activities of plated primary human 
hepatocytes (PHHs). Enzyme activity of PHHs was determined after initial adherence (T0) and addi-
tional 24 h (T1) and 48 h (T2). The substrates are listed in Supplementary Table 2 and the correspond-
ing absolute values in Supplementary Tables 3 and 4. The activity is expressed as relative value from 
low activity (white) to high activity (dark green). 
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The resulting cell populations isolated 
without or with supplementation of glucose 
and insulin showed that the modified proce-
dure was able to improve the viability of 
PHHs. The results indicate that in more than 
half of the cases, glucose uptake was able to 
restore energy resources and to prevent cel-
lular death. In contrast, our data showed no 
effect of the modified protocol on the PHH 
yield isolated from the liver tissue pieces. 
Cutting a liver tissue piece in half for our 
modified isolation procedure results in 
slightly different tissue sizes with highly 
varying tissue and vessel architecture leading 
to different perfusion and digestion efficien-
cies. Therefore, the cell yields can vary in-
dependently of the protocol used and are not 
usable for further analysis. 
The investigation of intracellular neutral 
lipids revealed that only two donors with 
high BMI (>30) showed correlating high he-
patic lipid levels. In contrast, the PHHs from 
D1-H showed low intracellular lipid levels, 
despite a BMI of 26.3, and that the resected 
liver tissue was clearly classified with hepat-
ic steatosis higher than 25 % by the patho-
logical unit of University Medicine Leipzig. 
Microscopic investigations on a whole stea-
totic mouse liver revealed a heterogenic dis-
tribution of liver fat (Schwen et al., 2016). 
Therefore, a liver tissue sample from a pa-
tient diagnosed with steatosis can have a low 
lipid content. Consequently, hepatocytes 
from donor D1-H were regarded as a low-
BMI sample, and our groups were classified 
as LLCH and HLCH for further characteriza-
tion. 
The subsequent analysis of the glycogen 
content of PHHs revealed that only in one 
donor (HLCH-2) could an increase in the 
glycogen content be achieved. This donor 
had already full glycogen storage before the 
cell isolation procedure, as shown by the 
glycogen measurement in the corresponding 
tissue, suggesting that its PHHs had suffi-
cient energy resources, enabling the storage 
of additional glucose in the form of glyco-
gen. In contrast, the inability to store the of-
fered glucose during perfusion suggests that 
most of the donor tissues had an emergent 
energy demand. Cellular regeneration and 
isolation stress are major processes requiring 
sufficient energy resources. Due to hypoxia 
and reoxygenation during surgery and cell 
isolation, reactive oxygen species (ROS) are 
produced. This response varies for PHHs 
originating from normal tissue, normal re-
sected tissue and diseased tissue (Bhogal et 
al., 2010). Proteomic analysis of PHHs ex-
posed to hypoxia and reoxygenation con-
firmed that peroxisomal detoxification and 
oxidative stress protection are energy-
demanding processes linked to enhanced 
glucose and glycogen metabolism (Strey et 
al., 2010). Metabolic analysis confirmed a 
decrease in antioxidative metabolites, citric 
acid cycle intermediates and several energet-
ic metabolites in freshly isolated PHHs (Cas-
sim et al., 2017). Consequently, supplemen-
tation with glucose and insulin led to a via-
bility gain in most of the isolated PHH 
batches. These data are in accordance with 
Zeilinger and colleagues showing in vitro 
that glucose supplementation protects 
hepatocytes from cell membrane damage 
during hypoxia/reoxygenation (Zeilinger et 
al., 1997). Correlating with viability, the rel-
ative adherence was also improved after 
supplementation with glucose and insulin, 
which was more pronounced in HLCH. The 
adherence requires a turnover of the plasma 
membrane to regenerate surface proteins 
damaged by the proteolytic cell isolation 
procedure. As the membrane regeneration of 
the cells is energy-dependent, a low glucose 
level limits the adherence in stressed hepato-
cytes. Analysis of attached and non-attached 
cryopreserved human hepatocytes showed an 
altered energy metabolism towards a stress-
related glycolytic phenotype in proteomic 
analysis (Ölander et al., 2019) and a down-
regulation of adhesion proteins in tran-
scriptomic analysis (Terry et al., 2007). 
Therefore, energetically stabilized and glu-
cose-supplemented PHHs could have an ad-
vantage regarding their adherence capacity. 
However, the adherence was generally 
very low in HLCH, independent of the sup-
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plementation. The investigation of the lipid 
content revealed that supplementation with 
glucose and insulin during the PHH isolation 
procedure can lead to different lipid contents 
in PHHs. As the de novo lipogenesis of tri-
glycerides from glucose requires hours, if 
not days (Davidson et al., 2016), we do not 
expect that the short-term supplementation 
with glucose and insulin during the isolation 
procedure can alter the lipid content of 
hepatocytes. However, supplementation can 
influence the survival of PHH subpopula-
tions with varying lipid content, leading to 
alterations in the overall lipid content. In this 
regard, supplementation with glucose and in-
sulin showed no or only small changes in the 
lipid content in LLCH. In contrast, HLCH 
showed a drop in the lipid content when sup-
plemented with glucose and insulin during 
the cell isolation procedure, suggesting that 
PHHs with low lipid content are rescued due 
to supplementation. 
Furthermore, a massive decrease in ad-
herence was observed in HLCH independent 
of the supplementation. Green and cowork-
ers observed that after plating hepatocytes, 
the remaining viable cells floating in the me-
dia had approximately threefold higher tri-
acylglycerol content than the adherent cells 
(Green et al., 2017), showing that hepato-
cytes that exceed a certain amount of lipid 
content were unable to adhere. We therefore 
hypothesize that the number of PHHs with 
high lipid content is increased without sup-
plementation, which is linked to an enrich-
ment of PHHs with reduced adherence. In 
contrast, supplementation with glucose and 
insulin leads to survival of low lipid-
containing PHHs and, consequently, better 
adherence. 
In general, the adherence and viability of 
a cell population correlates with its cell ac-
tivity. However, only HLCH showed a corre-
lation of the cell activity with increasing via-
bility and adherence of PHHs. Therefore, 
other factors may influence cell activity. Our 
isolated PHH suspension represents a mixed 
population of periportal and pericentral 
hepatocytes with different metabolic activi-
ties. As demonstrated by Halpern and 
coworkers, periportal hepatocytes in mice 
show that the oxidative phosphorylation 
pathway is expressed higher in periportal 
hepatocytes, where the oxygen concentration 
is higher (Halpern et al., 2017). Therefore, 
the cell activity measured in relation to 
NADPH and NADH concentration, as well 
as dehydrogenase activity, should be higher 
in periportal hepatocytes. The results indi-
cate that performing the cell isolation with-
out or with supplementation of glucose and 
insulin may have an effect on enriching PHH 
subpopulations differing in their cellular ac-
tivities. We expected that an initial im-
provement of the energy resources also af-
fects the regeneration of the cells in culture. 
Additionally, an effect of the isolation pro-
cedure on the selection of PHH populations 
should also be observable through functional 
parameters. 
 
Influence of supplementation on hepatic 
functions 
Therefore, we investigated differentiated 
hepatic functions of cultured PHHs isolated 
with and without supplementation of glucose 
and insulin. We decided to perform the in-
vestigations in a classic 2D culture because 
this culture was stable for at least 3 days 
(Knobeloch et al., 2012). The initial (T0) 
synthesis of albumin und urea in PHHs iso-
lated with and without supplementation of 
glucose and insulin showed no difference be-
tween both procedures in most PHH batches. 
During the ongoing cell culture (T1 and T2), 
half of the PHH batches were able to main-
tain or restore albumin synthesis capacities, 
while in the others, the albumin synthesis 
dropped. These observations were independ-
ent of the BMI of the donors. In contrast, the 
urea synthesis capacity shows a clear ten-
dency to lose activity during the cultivation 
time using our cell culture protocol. Two do-
nors (D4-H, D5-H) showed a striking identi-
cal pattern of the initial values for albumin 
and urea, suggesting that both synthesis ac-
tivities can be traced to the same hepatocyte 
population. The elucidation of lobular liver 
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functions revealed that urea synthesis is per-
formed mainly in the periportal zone, where-
as albumin is synthesized by hepatocytes 
over the whole sinusoid but shows higher ac-
tivities in the periportal zone, as well 
(Halpern et al., 2017). Consequently, the 
higher initial urea synthesis for the donors 
D4-L and D4-H suggests that supplementa-
tion with glucose and insulin can enrich the 
cell suspension with periportal hepatocytes. 
However, the general reduction of urea syn-
thesis in the majority of donors indicates that 
oxygen-dependent periportal PHHs have ei-
ther a shorter survival rate or lose these ac-
tivities due to adaption or dedifferentiation. 
Several studies have shown that the stabiliza-
tion or improvement of hepatic functions, 
such as production of urea or albumin, is ox-
ygen-dependent (Gilglioni et al., 2018; Kid-
ambi et al., 2009), and PHH cultures main-
tain hepatic functions when cultured in a 
physiological oxygen concentration (Guo et 
al., 2017). 
The investigations on CYP450 activities 
revealed the highest activities for the donors 
D4-L and D6-H. Both donors showed lower 
initial values when isolated with supplemen-
tation of glucose and insulin. PHHs from the 
other donors showed a similarly reduced ac-
tivity for the majority of CYP450 when iso-
lated with the modified protocol. Therefore, 
supplementation with glucose and insulin 
decreases CYP activities either by dediffer-
entiation or influences the percentage of 
CYP450-rich PHH subpopulations. Most 
CYP450 activities are located in the pericen-
tral region of the liver lobule (Oinonen and 
Lindros, 1998), which particularly applies 
for the isoenzymes CYP1A2, CYP2A6, 
CYP2C19, CYP2E1 and CYP3A4 investi-
gated in our study (McEnerney et al., 2017). 
Therefore, the results indicate that supple-
mentation with glucose and insulin leads to a 
dilution of a CYP450-rich pericentral 
hepatocyte population with additional peri-
portal hepatocytes that are low in CYP450 
activity. In contrast, the measured phase II 
enzyme activities were more stable or regen-
erated during the cultivation time, and the 
supplementation with glucose and insulin 
showed no striking initial difference. 
Many genes of phase II enzymes, e.g., 
several isoforms of glutathione-S-trans-
ferases and sulfotransferases, are expressed 
in pericentral hepatocytes, but specific 
isoforms of these metabolic pathways also 
appear exclusively in periportal hepatocytes 
(Braeuning et al., 2006). Most of the hepatic 
glucuronosyltransferases show an expression 
over the whole lobule with a higher expres-
sion in pericentral hepatocytes (Halpern et 
al., 2017). Thus, phase II metabolism is more 
equally distributed in general. As our assays 
did not allow us to distinguish between the 
specific conjugation pathways, the detection 
of differences in the hepatocyte subpopula-
tion ratio cannot be expected. This conclu-
sion is in line with our observations on un-
changed phase II activities between isolation 
without and with glucose and insulin sup-
plementation. 
The results correspond with observations 
that periportal hepatocytes are representative 
of high energy-consuming functions, such as 
albumin and urea synthesis and gluconeo-
genesis. Additionally, these cells are more 
sensitive to low oxygen levels, leading to 
adaption, dedifferentiation and loss of viabil-
ity (Gilglioni et al., 2018; Kidambi et al., 
2009; Kietzmann, 2017). In contrast, peri-
central hepatocytes are characteristic of gly-
cogen synthesis from glucose, lipid storage 
and xenobiotic metabolism and are less sen-
sitive to hypoxia. 
 
SUMMARY, LIMITATIONS AND  
ISOLATION RECOMMENDATION 
Taken together, patient parameters, the 
surgical procedure and tissue handling can 
decrease hepatic energy resources and can 
lead to cell stress and cell death. Our modi-
fied protocol for the isolation of PHHs re-
stores hepatic energy resources. Even if the 
hepatic glycogen level was unchanged, an 
indirect improvement of the availability of 
energy was shown by increased viability, 
plating efficiency and partial cellular activi-
ty. The plating efficiency showed a striking 
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inverse correlation with increasing lipid con-
tent of the hepatocytes. The initial supple-
mentation-dependent differences in lipid 
storage, albumin and urea synthesis, as well 
as xenobiotic metabolism, originate from 
changes in the isolated hepatocyte subpopu-
lations. Consequently, performing PHH iso-
lation without supplementation of glucose 
and insulin affects PHHs with low energy re-
sources that die during the isolation proce-
dure or the early cell culture. Supplementa-
tion with glucose and insulin during the liver 
cell isolation procedure improves the surviv-
al rates of hepatocytes with low energy re-
sources and shifts the ratio of different PHH 
subpopulations to a mixed population that is 
more representative of the entire liver lobule. 
However, the changed composition of isolat-
ed PHHs had no significant impact on the 
maintenance of hepatic function during a 
60 h cultivation time. 
The study is limited because the func-
tional characterization showed varying and 
highly donor-dependent results, which are 
typical when working with PHHs. Therefore, 
we supported our limited statistical analysis 
with the individual values for each batch, al-
lowing us to confirm results on different 
readouts for a broad range of characteriza-
tion parameters. In this study, we focused on 
factors that influence the energy resources, 
as they are affected by ischemia and hypox-
ia/reoxygenation and were identified as a 
major problem that is exacerbated by modern 
surgical methods. Despite these limitations, 
the study draws some conclusions that are 
true for the majority of investigated batches. 
Consequently, we recommend supple-
mentation with glucose and insulin because 
it improves the majority of PHH batches and 
leads to a cell suspension that better reflects 
the PHH populations of the entire liver lob-
ule. When parameters in cell characterization 
must be determined absolutely (as in CYP 
assays), the most stable time frame is 36 h 
after seeding the cells; otherwise, an analysis 
relative to a control group is recommended 
(treated cells vs. control/untreated cells). 
Further research is needed to characterize 
the influence of the isolation procedure on 
the selection and the final ratio of hepatocyte 
subpopulations. Additionally, further re-
search on the improvement in liver cell cul-
ture is warranted to maintain hepatic func-
tions in more vulnerable hepatocyte popula-
tions. Hence, the optimization of existing 
isolation and cultivation protocols is a pre-
requisite for guaranteeing high quantities of 
high-quality PHHs. 
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